A service of the U.S. National Library of Medicine
National Institutes of Health Hepatitis B vaccine protects for 25 years: study
Wednesday, June 20, 2012
By Aparna Narayanan
NEW YORK (Reuters Health) - Vaccination against hepatitis B seems to protect against the virus for 25 years, suggesting booster shots are unnecessary, according to a new study from Taiwan.
"Universal vaccination in infancy provides long-term protection," Dr. Yen-Hsuan Ni, the study's lead author from the National Taiwan University in Taipei, wrote in an e-mail.
Taiwan mandated hepatitis B virus (HBV) immunization for all infants in 1984, in response to extremely high rates of infection. Hepatitis B infection is a prime cause of liver cancer, the second most common cancer type in Taiwan.
In 2009, study participants younger than age 25 were far less likely to be infected than those between the ages of 26 and 30 -- who were born before universal vaccination, the researchers found.
"It's efficacy in young adults is clear," Ni told Reuters Health, explaining that medical experts had questions about how long the vaccine's protective effect would last. Booster shots, which are generally not recommended for hepatitis B, were not given to subjects in the study.
The findings reinforce five previous surveys -- done at five-yearly intervals since 1984 -- which also found lower infections among those born after the mandate.
Under the Taiwanese program, infants born to infected mothers also get a shot of a protein to fight against the virus known as an antibody within 24 hours of birth, but this did not completely eliminate the spread of the virus from mother to child, the study noted.
"Mother-to-infant transmission remains the key route of vaccine failure that needs to be overcome," Ni said.
The study, published in the Journal of Hepatology, suggests that other countries may benefit from including compulsory hepatitis B vaccination for infants.
Hepatitis B is a viral infection that attacks the liver. The virus is spread by contact with the blood or other bodily fluids of an infected person.
An estimated 350 million people worldwide have the hepatitis B virus. Almost 100,000 new people are infected each year in the United States, according to the non-profit Hepatitis B Foundation.
The World Health Organization recommends hepatitis B shots for all babies. The three-part vaccine series usually costs $75 to $165, and is available often free of charge from health clinics. Common side effects include soreness, swelling and redness where the shot is injected.
BOOSTER SHOTS UNNECESSARY
For the new study, funded by the National Taiwan University Hospital, Ni and his colleagues enrolled more than 3,300 participants under 30. Of these subjects, more than 2,900 -- born after the mandate -- received at least three doses of vaccine in their first year. Approximately 370 subjects, born before 1984, were not universally vaccinated.
When they collected blood samples from January to December 2009, Ni's team found that less than one percent of the universally vaccinated group carried the virus and were infectious to others, compared with 10 percent of those who weren't universally vaccinated.
Among subjects over age 20, the infection rate did not increase significantly from 1989 to 2009, making universal booster doses unnecessary, the study noted.
Fifty-six percent of those born after universal vaccination developed immunity to the disease, versus 24 percent in the group born before it began. Seven percent of the group that was universally vaccinated had an infection in their history but possibly had recovered, compared with 28 percent of the group that was not.
Most cases of vaccine failure were related to the mother's status, the study found. Of the 25 subjects who developed an infection despite getting immunized, 86 percent had mothers who carried the virus.
Globally, gaps in treatment -- including spread of the virus from mother to baby -- need to be plugged to eliminate hepatitis B, said Dr. Solomon Chen, a visiting fellow in global health at the Harvard School of Public Health.
"The issue of vaccine failure due to intrauterine transmission should be overcome," Chen, who was not involved in this study but studied under its authors in Taiwan, told Reuters Health.
SOURCE: http://bit.ly/NU4fKa Journal of Hepatology, online June 4, 2012.
NEW YORK (Reuters Health) - Vaccination against hepatitis B seems to protect against the virus for 25 years, suggesting booster shots are unnecessary, according to a new study from Taiwan.
"Universal vaccination in infancy provides long-term protection," Dr. Yen-Hsuan Ni, the study's lead author from the National Taiwan University in Taipei, wrote in an e-mail.
Taiwan mandated hepatitis B virus (HBV) immunization for all infants in 1984, in response to extremely high rates of infection. Hepatitis B infection is a prime cause of liver cancer, the second most common cancer type in Taiwan.
In 2009, study participants younger than age 25 were far less likely to be infected than those between the ages of 26 and 30 -- who were born before universal vaccination, the researchers found.
"It's efficacy in young adults is clear," Ni told Reuters Health, explaining that medical experts had questions about how long the vaccine's protective effect would last. Booster shots, which are generally not recommended for hepatitis B, were not given to subjects in the study.
The findings reinforce five previous surveys -- done at five-yearly intervals since 1984 -- which also found lower infections among those born after the mandate.
Under the Taiwanese program, infants born to infected mothers also get a shot of a protein to fight against the virus known as an antibody within 24 hours of birth, but this did not completely eliminate the spread of the virus from mother to child, the study noted.
"Mother-to-infant transmission remains the key route of vaccine failure that needs to be overcome," Ni said.
The study, published in the Journal of Hepatology, suggests that other countries may benefit from including compulsory hepatitis B vaccination for infants.
Hepatitis B is a viral infection that attacks the liver. The virus is spread by contact with the blood or other bodily fluids of an infected person.
An estimated 350 million people worldwide have the hepatitis B virus. Almost 100,000 new people are infected each year in the United States, according to the non-profit Hepatitis B Foundation.
The World Health Organization recommends hepatitis B shots for all babies. The three-part vaccine series usually costs $75 to $165, and is available often free of charge from health clinics. Common side effects include soreness, swelling and redness where the shot is injected.
BOOSTER SHOTS UNNECESSARY
For the new study, funded by the National Taiwan University Hospital, Ni and his colleagues enrolled more than 3,300 participants under 30. Of these subjects, more than 2,900 -- born after the mandate -- received at least three doses of vaccine in their first year. Approximately 370 subjects, born before 1984, were not universally vaccinated.
When they collected blood samples from January to December 2009, Ni's team found that less than one percent of the universally vaccinated group carried the virus and were infectious to others, compared with 10 percent of those who weren't universally vaccinated.
Among subjects over age 20, the infection rate did not increase significantly from 1989 to 2009, making universal booster doses unnecessary, the study noted.
Fifty-six percent of those born after universal vaccination developed immunity to the disease, versus 24 percent in the group born before it began. Seven percent of the group that was universally vaccinated had an infection in their history but possibly had recovered, compared with 28 percent of the group that was not.
Most cases of vaccine failure were related to the mother's status, the study found. Of the 25 subjects who developed an infection despite getting immunized, 86 percent had mothers who carried the virus.
Globally, gaps in treatment -- including spread of the virus from mother to baby -- need to be plugged to eliminate hepatitis B, said Dr. Solomon Chen, a visiting fellow in global health at the Harvard School of Public Health.
"The issue of vaccine failure due to intrauterine transmission should be overcome," Chen, who was not involved in this study but studied under its authors in Taiwan, told Reuters Health.
SOURCE: http://bit.ly/NU4fKa Journal of Hepatology, online June 4, 2012.
Reuters Health
(c) Copyright Thomson Reuters 2012. Check for restrictions at: http://about.reuters.com/fulllegal.asp
- More Health News on:
- Childhood Immunization
- Hepatitis B
Childhood Immunization
Also called: ShotsToday, children in the United States routinely get vaccines that protect them from more than a dozen diseases such as measles, polio and tetanus. Most of these diseases are now at their lowest levels in history, thanks to years of immunization. Children must get at least some vaccines before they may attend school. Vaccines help make you immune to serious diseases without getting sick first. Without a vaccine, you must actually get a disease in order to become immune to the germ that causes it. Vaccines work best when they are given at certain ages. For example, children don't receive measles vaccine until they are at least one year old. If it is given earlier it might not work as well. The Centers for Disease Control and Prevention publishes a schedule for childhood vaccines. Although some of the vaccines you receive as a child provide protection for many years, adults need immunizations too.Centers for Disease Control and Prevention06/17/2012 08:00 PM EDTExperts fear parents are jeopardizing their babies' healthMEDICAL ENCYCLOPEDIA
Languages
- Arabic (العربية)
- Armenian (Հայերեն)
- Bosnian (Bosanski)
- Burmese (myanmasa)
- Chinese - Simplified (简体中文)
- Chinese - Traditional (繁體中文)
- Croatian (Hrvatski)
- Farsi (فارسی)
- French (français)
- German (Deutsch)
- Haitian Creole (Kreyol)
- Hindi (हिन्दी)
- Hmong (Hmoob)
- Ilocano (ilokano)
- Japanese (日本語)
- Khmer (Khmer)
- Korean (한국어)
- Laotian (Lao)
- Panjabi (ਪੰਜਾਬੀ)
- Polish (polski)
- Portuguese (português)
- Romanian (Română)
- Russian (Русский)
- Samoan (Gagana Samoa)
- Somali (af Soomaali)
- Spanish (español)
- Tagalog (Tagalog)
- Thai (ภาษาไทย)
- Turkish (Türkçe)
- Vietnamese (Tiếng Việt)
.png)
No hay comentarios:
Publicar un comentario